Complexa, Inc.
Pittsburgh, PA, US· latest recorded location
COMPLEXA, INC. is named on 5 US grants and 16 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 5
- Published applications
- 16
- Inventors
- 7
- Granted in 2026 so far
- 0
- Most recent grant
- 21 Jan 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 3 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 2 |
| 2017 | 2 | 3 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 1 |
By publication year.
Technology areas
Share of 21 documents
Recent patents
- Treatment of focal segmental glomerular sclerosis (FSGS) using therapeutically effective oral doses of 10-nitro-9(E)-octadec-9-enoic acid21 Jan 2020US 10,537,541 B2
- Vinyl substituted fatty acids17 Oct 2017US 9,790,167 B2
- Heteroatom containing substituted fatty acids30 May 2017US 9,663,444 B2
- Compositions and methods for treating nephropathy1 Mar 2016US 9,271,952 B2
- Heteroatom containing substituted fatty acids1 Apr 2014US 8,686,167 B2
- Vinyl substituted fatty acids23 Dec 2021US 2021/0395184 A1
- Vinyl substituted fatty acids1 Oct 2020US 2020/0308096 A1
- Treatment of pulmonary arterial hypertension using therapeutically effective oral doses of 10-nitro-9(e)-octadec-9-enoic acid13 Feb 2020US 2020/0046669 A1
- Vinyl substituted fatty acids28 Dec 2017US 2017/0369419 A1
- Heteroatom containing substituted fatty acids27 Apr 2017US 2017/0113999 A9
Most cited
By later US patents